Reappraisal of Blood Markers in Sudden Sensorineural Hearing Loss Using a Single-Center OMOP Common Data Model: Associations with Onset, Baseline Severity, and Recovery Across Clinical Axes and Sampling Timings
Diagnostics · 18.11.2026 · 16 (22) · 3843
DOI: 10.3390/diagnostics16223843 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 18.11.2026. Verfasst von Chul Young Yoon und 6 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Commercialization Promotion Agency for R&D Outcomes, Korea Evaluation Institute of Industrial Technology.
Abstract (Originalsprache)
Background/Objectives: This study aimed to reappraise the practice of treating admission-day blood values as a fixed baseline in sudden sensorineural hearing loss (SSNHL). Blood markers were grouped into clinical axes A (acute cellular stress), B (reserve/protein), and C (acute-phase response) and tested for associations with onset, baseline pure-tone average (PTA), and recovery at timings E0, Eb, and Δ.
Methods
First SSNHL episodes were identified in a single-center OMOP CDM (n = 5311; 2002–2025). Markers were classified into three clinical axes (A/B/C), and sampling timing was separated into E0, Eb, and Δ. Prespecified hypotheses were H1 (onset OR for Eb 36-month NLR, TP, and Glb), H2 (E0 albumin–PTA), and H3 (E0 CAR–PTA). Onset used 1:4 age–sex matched odds ratios; PTA used linear regression; recovery used logistic regression. Exploratory analyses were controlled with Benjamini–Hochberg FDR. Recovery sensitivity definitions and indication-stratified rematching were applied.
Results
Under H1, onset ORs were NLR 1.05 (1.03–1.07), TP 0.81 (0.73–0.90), and Glb 0.83 (0.73–0.95). Under H2, E0 albumin–PTA β was −12.94 (−17.49 to −8.40; q < 0.001). Under H3, E0 CAR–PTA β was 6.88 (1.61–12.15; q = 0.039). E0 NLR was unrelated to PTA. Recovery remained null after definition diversification and FDR. After indication-stratified rematching, the NLR onset OR and E0 albumin/CAR–PTA signals were retained.
Conclusions
SSNHL blood markers should be reported by clinical axis (A/B/C) and sampling timing (E0/Eb/Δ). Onset and baseline-severity signals persist after indication adjustment, whereas evidence for recovery prediction remains weak.
Förderung
- National Research Foundation of Korea
- Commercialization Promotion Agency for R&D Outcomes
- Korea Evaluation Institute of Industrial Technology
- KRISS
- Ministry of Education
Zitieren
APA
Yoon, C. Y., Kim, S., Kim, J. S., Im, S., Seo, Y. H., Yoon, D., & Seo, Y. J. (2026). Reappraisal of Blood Markers in Sudden Sensorineural Hearing Loss Using a Single-Center OMOP Common Data Model: Associations with Onset, Baseline Severity, and Recovery Across Clinical Axes and Sampling Timings. Diagnostics, 16(22), 3843. https://doi.org/10.3390/diagnostics16223843
Vancouver
Yoon CY, Kim S, Kim JS, Im S, Seo YH, Yoon D, et al. Reappraisal of Blood Markers in Sudden Sensorineural Hearing Loss Using a Single-Center OMOP Common Data Model: Associations with Onset, Baseline Severity, and Recovery Across Clinical Axes and Sampling Timings. Diagnostics. 2026;16(22):3843. doi:10.3390/diagnostics16223843
BibTeX
@article{Yoon2026,
author = {Yoon, Chul Young and Kim, SongYi and Kim, Jin Su and Im, Seungmi and Seo, Yeon Ho and Yoon, Dam and Seo, Young Joon},
title = {Reappraisal of Blood Markers in Sudden Sensorineural Hearing Loss Using a Single-Center OMOP Common Data Model: Associations with Onset, Baseline Severity, and Recovery Across Clinical Axes and Sampling Timings},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {22},
pages = {3843},
doi = {10.3390/diagnostics16223843}
}
EUVIMED